Map My Customers

MARCH 31, 2022

Not only is this field interesting and competitive, but it can also be lucrative. As a pharmaceutical sales rep, there are appointments and meetings with doctors and professionals that need to stay up to date with the latest pharmacology treatment options for their patients.

Medical sales reps 52

Medical sales reps Medical sales Sales Medical 52

European Pharmaceutical Review

OCTOBER 19, 2022

2 Recently, the US Patent and Trademark Office (US PTO) reiterated the concern that patents have been “misused to inhibit and delay – for years and even decades – competition from generic drugs and biosimilars, denying Americans access to lower-cost drugs.” Cited 25 September 2022]. Cited 25 September 2022]. September 09, 2022.

Food and Drug Administration 96

Food and Drug Administration Pharmaceutical products Pharmaceutical FDA 96

pharmaphorum

JANUARY 4, 2023

It looks like Astellas has been unsuccessful in its attempt to block Pfizer’s generic medicines unit Hospira from launching a copycat version of big-selling pharmacologic stress agent Lexiscan in the US. The drug was originally developed by CV Therapeutics – bought by Gilead in 2009 – and first launched in the US in 2008.

Pharmacology 59

Pharmacology Marketing Pharma Competition 59

MedCity News

JUNE 16, 2023

The consensus is 2022 was a challenging year for digital health companies. billion in 2022 — down 56% from $40.2 billion in 2022 — down 56% from $40.2 Rather, 2022 represents an overdue correction in the midst of global economic uncertainty after a period of overexuberance and lofty expectations in digital health.

Pharma 110

Pharma Food and Drug Administration Recruitment Patients 110

Impetus Digital

AUGUST 2, 2024

In 2022, the AI-fuelled pipeline reportedly expanded at an annual rate of almost 40%. Market Analysis and Competitive Intelligence AI tools can analyze vast amounts of data from various sources to provide insights into market trends, competitor activities, and emerging opportunities.

Pharma 95

Pharma Manufacturing Medicine Marketing 95

pharmaphorum

JANUARY 16, 2023

Last year, IQVIA predicted that 2022 would be the crunch year for Alzheimer’s therapies: it is with a sense of déjà vu that the exact same prediction is contemplated for 2023. The European Medicine Agency-approved Biomarin’s Haemophilia A gene therapeutic, Roctavian, in 2022, and it is expected to be approved by the FDA in 2023.

FDA 85

FDA Healthcare Healthcare Medicine 85

European Pharmaceutical Review

JULY 4, 2024

She also holds post-graduate diplomas from Oxford (IP Law) as well as King’s College (EU Competition Law). 2022 [cited 2024May]. She obtained a degree in physics from MIT prior to attending University of Pennsylvania Law School. National Institutes of Health (NIH) Available from: [link] Ahn K. researchspace.auckland.ac.nz.

Marketing 103

Marketing Food and Drug Administration Medicine Prescription 103